Key clinical point: Medication overuse is prevalent among U.S. migraine patients and significantly links with impaired function and disability.
Major finding: Medication overuse occurred in 18% of surveyed U.S. residents who met the study’s definition of having migraine.
Study details: Analysis of survey results from the CaMEO study, with 16,789 U.S. residents identified with migraine.
Disclosures: CaMEO was funded by Allergan. Dr. Schwedt has been a consultant to Allergan, and also to Alder, Amgen, Cipla, Dr. Reddy’s, Ipsen, Lilly, Novartis, and Teva; he had stock ownership in Aural Analytics, Nocira, and Second Opinion; and he has received research funding from Amgen.
Schwedt TJ et al. Headache. 2019 June;59[S1]:83-4, Abstract P92